Literature DB >> 11359467

Relation of cardiac abnormalities and CTG-repeat size in myotonic dystrophy.

J Finsterer1, E Gharehbaghi-Schnell, C Stöllberger, K Fheodoroff, A Seiser.   

Abstract

It is unclear if the severity of cardiac involvement in patients with myotonic dystrophy (MD) is related to the size of the CTG-repeat expansion. This open, uncontrolled, observational, prospective study aimed to find out if there is a relation between the severity of cardiac involvement in MD and the CTG-repeat size. In 21 patients with MD, (8 women, 13 men, aged 11-88 years) a detailed cardiologic examination, including history, clinical examination, electrocardiography (ECG), transthoracic echocardiography and ambulatory 24-h ECG, was carried out and cardiac involvement was assessed according to a previously described scoring system. Additionally, the CTG-repeat size was determined from nuclear DNA of blood leukocytes. The correlation between the CTG-repeat size and the mean heart rate, PQ-interval, QTc-interval, fractional shortening, left ventricular enddiastolic diameter, septal thickness, posterior wall thickness, mean heart rate on 24-h ECG and cardiac involvement score was r=0.47, r=0.086, r=0.11, r=-0.27, r=-0.34, r=-0.06, r=-0.12, r=0.16 and r=0.09 (all p>0.05), respectively. In patients 21-30, 31-40 and 41-50 years of age, cardiac involvement increased with increasing CTG-repeat size. In younger patients, the number of CTG-repeats needed to develop a reasonable cardiac involvement was higher than in older patients. Depending on age, cardiac involvement increases with increasing CTG-repeat size obtained from blood leukocytes in patients with MD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359467     DOI: 10.1034/j.1399-0004.2001.590509.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

1.  Molecular characterization of the mouse In(10)17Rk inversion and identification of a novel muscle-specific gene at the proximal breakpoint.

Authors:  Kathleen F Benson; Kiran Chada
Journal:  Genetics       Date:  2002-01       Impact factor: 4.562

Review 2.  [Cardiac manifestations of muscular dystrophies].

Authors:  A Perrot; S Spuler; C Geier; R Dietz; K J Osterziel
Journal:  Z Kardiol       Date:  2005-05

3.  Natural history of skeletal muscle involvement in myotonic dystrophy type 1: a retrospective study in 204 cases.

Authors:  Jean-Pierre Bouchard; Louise Cossette; Guillaume Bassez; Jack Puymirat
Journal:  J Neurol       Date:  2014-11-08       Impact factor: 4.849

4.  Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.

Authors:  Evrim B Turkbey; Neville Gai; João A C Lima; Rob J van der Geest; Kathryn R Wagner; Gordon F Tomaselli; David A Bluemke; Saman Nazarian
Journal:  Heart Rhythm       Date:  2012-06-16       Impact factor: 6.343

5.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

Review 6.  Molecular genetics and genetic testing in myotonic dystrophy type 1.

Authors:  Dušanka Savić Pavićević; Jelena Miladinović; Miloš Brkušanin; Saša Šviković; Svetlana Djurica; Goran Brajušković; Stanka Romac
Journal:  Biomed Res Int       Date:  2013-03-18       Impact factor: 3.411

7.  Prolonged Corrected QT Interval in Patients with Myotonic Dystrophy Type 1.

Authors:  Kang Min Park; Kyong Jin Shin; Sung Eun Kim; Jinse Park; Sam Yeol Ha; Byoung Joon Kim
Journal:  J Clin Neurol       Date:  2013-07-01       Impact factor: 3.077

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.